1 by: abdulaziz bin saeedan p h.d. department of pharmacology e mail: p harmacology – iv phl-425...
DESCRIPTION
3 Alkylating agents Cyclophosphamide Cisplatin Procarbazine Busulfan MechlorethamineTRANSCRIPT
11
By:By:
Abdulaziz bin SaeedanAbdulaziz bin SaeedanPPh.D.h.D.Department of PharmacologyDepartment of Pharmacology E mail: E mail: [email protected]@sau.edu.sa
PPharmacology – IVharmacology – IVPHL-425PHL-425
ChapterChapter 3: 3:
CANCER CHEMOTHERAPY CANCER CHEMOTHERAPY
22
Classification Classification
Cell Cycle–Specific (CCS) Agents Cell Cycle–Nonspecific (CCNS) Agents
Antimetabolites (S phase) Alkylating agents Capecitabine Altretamine Cladribine Bendamustine Clofarabine Busulfan Cytarabine (ara-C) Carmustine Fludarabine Chlorambucil 5-Fluorouracil (5-FU) Cyclophosphamide Gemcitabine Dacarbazine 6-Mercaptopurine (6-MP) Lomustine
Methotrexate (MTX) Mechlorethamine 6-Thioguanine (6-TG) Melphalan
Temozolomide Epipodophyllotoxin (topoisomerase II inhibitor) (G1–S phase)
Thiotepa
Etoposide Anthracyclines Taxanes (M phase) Daunorubicin Albumin-bound paclitaxel Doxorubicin Docetaxel Epirubicin Paclitaxel Idarubicin Vinca alkaloids (M phase) Mitoxantrone
Vinblastine Antitumor antibiotics
Vincristine Dactinomycin Vinorelbine Mitomycin Antimicrotubule inhibitor (M phase) Camptothecins (topoisomerase I
inhibitors) Ixabepilone Irinotecan
Topotecan Antitumor antibiotics (G2–M phase) Platinum analogs
Bleomycin Carboplatin Cisplatin
33
Alkylating agentsAlkylating agents
Cyclophosphamide Cyclophosphamide CisplatinCisplatin Procarbazine Procarbazine BusulfanBusulfan Mechlorethamine Mechlorethamine
44
MOAMOA Alkylating agents
Contain chem grps that Contain chem grps that covalently bind cell covalently bind cell nucleophilesnucleophiles
Impt properties of drugsImpt properties of drugs Can form carbonium ionsCan form carbonium ions Bifunctional (2 reactive grps)Bifunctional (2 reactive grps)
Allow cross-linkingAllow cross-linking DNA becomes cross-linked w/ agentDNA becomes cross-linked w/ agent
Intra- or inter-strandIntra- or inter-strand Decr’d transcr’n, repl’nDecr’d transcr’n, repl’n Chain scission, so strand Chain scission, so strand
breaksbreaks
55
Alkylating Agents- Alkylating Agents- Used in wide variety of Used in wide variety of hematologic and solid tumorshematologic and solid tumors
Thiotepa – Thiotepa – ovarian cancerovarian cancer Busulfan Busulfan -Pulmonary fibrosis.-Pulmonary fibrosis. ***Nitrosoureas***Nitrosoureas (Carmustine and lomustine ) - brain (Carmustine and lomustine ) - brain
tumorstumors Highly lipid soluble drugs hence reach high concentration in the Highly lipid soluble drugs hence reach high concentration in the
brain and CSF. brain and CSF. StreptozocinStreptozocin – insulin-secreting islet cell carcinoma of – insulin-secreting islet cell carcinoma of
the pancreasthe pancreas Mechlorethamine Mechlorethamine – Prodrug.– Prodrug. It is a highly irritant drug so It is a highly irritant drug so
care should be taken to avoid extravasation during IV care should be taken to avoid extravasation during IV administrationadministration
Chlorambucil (Leukeran):Chlorambucil (Leukeran): Slow acting and least toxic Slow acting and least toxic nitrogen mustard. nitrogen mustard.
66
Cyclophosphamide Cyclophosphamide It is a prodrug and is activated by the P-It is a prodrug and is activated by the P-
450 enzymes to its active form 450 enzymes to its active form phosphoramide mustardphosphoramide mustard
The active drug alkylates nucleophilic The active drug alkylates nucleophilic groups on DNA basesgroups on DNA bases Particularly at the N-7 position of guanineParticularly at the N-7 position of guanine
This leads to cross linking of bases, This leads to cross linking of bases, abnormal base pairing and DNA strand abnormal base pairing and DNA strand breakagebreakage
77
88
99
Mechanism of resistanceMechanism of resistance
The mechanisms mentioned below are The mechanisms mentioned below are common for all the alkylyting agentscommon for all the alkylyting agents
Increased DNA repairIncreased DNA repair Decreased drug permeabilityDecreased drug permeability Production of “trapping” agents (thiols)Production of “trapping” agents (thiols)
1010
Uses Uses
Non-Hodgkin’s lymphomaNon-Hodgkin’s lymphoma Breast CancerBreast Cancer Ovarian CancerOvarian Cancer Neuroblastoma Neuroblastoma
1111
ADRADR Acrolein is the metaboliteAcrolein is the metabolite Responsible for causing hemorrhagic Responsible for causing hemorrhagic
cystitiscystitis Suprapubic painSuprapubic pain HematuriaHematuria Cyctoscopic findings Cyctoscopic findings
This is prevented/treated by This is prevented/treated by MESNA (mercaptoethanesulfonate)MESNA (mercaptoethanesulfonate)
Rarely cyclophosphamide can cause Rarely cyclophosphamide can cause pulmonary toxicitypulmonary toxicity
1212
1313
Cisplatin Cisplatin Platinum analogPlatinum analog Same MOA as cyclophosphamideSame MOA as cyclophosphamide **Used in testicular carcinoma**Used in testicular carcinoma Also used for Ca of bladder, lung and ovaryAlso used for Ca of bladder, lung and ovary Carboplatin is new drug with better safety profileCarboplatin is new drug with better safety profileADRADR Nephrotoxicity (prevented by Amifostine)Nephrotoxicity (prevented by Amifostine) Ototoxicity (acoustic nerve damage)Ototoxicity (acoustic nerve damage) Peripheral neuritisPeripheral neuritis Severe nausea and vomiting Severe nausea and vomiting
1414
Procarbazine Procarbazine
MOA: forms hydrogen peroxide, which MOA: forms hydrogen peroxide, which generates free radicals that cause DNA generates free radicals that cause DNA damagedamage
Important component of regimens Important component of regimens especially for Hodgkin’s lymphomaespecially for Hodgkin’s lymphoma
ADRADR Disulfiram like reactionsDisulfiram like reactions
1515
Antimetabolites
Folic Acid Analogs Purine Analogs Pyrimidine Analogs
Methotrexate Mercaptoguanine Fluorouracil
TrimetrexatePemetrexed
ThioguanineFludarabine PhosphateCladribine
Cytarabine GemcitabineCapecitabine
They are structurally similar to endogenous compoundsThey are structurally similar to endogenous compounds They act as antagonists of:They act as antagonists of:
Folic acid (methotrexate)Folic acid (methotrexate) Purines (Mercaptopurine and thioguanine)Purines (Mercaptopurine and thioguanine) Pyrimidine (fluorouracil, cytarabine)Pyrimidine (fluorouracil, cytarabine)
1616
Antimetabolits: sites of drug actionAntimetabolits: sites of drug action
1717
Methotrexate Methotrexate
1818
Methotrexate (MTX)Methotrexate (MTX) MTX is a folic acid analog that binds with high affinity to the MTX is a folic acid analog that binds with high affinity to the
active catalytic site of dihydrofolate reductase (DHFR)active catalytic site of dihydrofolate reductase (DHFR)
Thus it interferes with the synthesis of tetrahydrofolate (THF)Thus it interferes with the synthesis of tetrahydrofolate (THF)
THF serves as the key one-carbon carrier for enzymatic THF serves as the key one-carbon carrier for enzymatic processes involved in de novo synthesis of thymidylate, processes involved in de novo synthesis of thymidylate, purine nucleotides, and the amino acids serine and purine nucleotides, and the amino acids serine and methionine. methionine.
Inhibition of these various metabolic processes thereby Inhibition of these various metabolic processes thereby interferes with the formation of DNA, RNA, and key cellular interferes with the formation of DNA, RNA, and key cellular proteins. proteins.
1919
Mechanism of Resistance
1. Decreased drug transport
2. Altered DHFR3. Decreased
polyglutamate formation
4. Increased levels of DHFR
2020
MTXMTX Most commonly used anticancer drug. Most commonly used anticancer drug. Cell cycle specific (CCS) drug and acts during S phase of the cell cycle. Cell cycle specific (CCS) drug and acts during S phase of the cell cycle. Antineoplastic, immunosuppressant and antiinflammatoryAntineoplastic, immunosuppressant and antiinflammatory Used in RA, psoriasisUsed in RA, psoriasis Well absorbed orally; can also be given IM, IV or intrathecally. Well absorbed orally; can also be given IM, IV or intrathecally. It is bound to plasma proteins, It is bound to plasma proteins, does not cross the BBBdoes not cross the BBB and most of the drug and most of the drug
is excreted unchanged in urine.is excreted unchanged in urine. It is a weak acid and so is excreted better at high urine pH. Appropriate It is a weak acid and so is excreted better at high urine pH. Appropriate
hydration and alkalinizing the urine is important to prevent renal tox with MTXhydration and alkalinizing the urine is important to prevent renal tox with MTX
ADR:ADR: Bone marrow suppression (BMS)Bone marrow suppression (BMS) Folic acid deficiency Folic acid deficiency The toxic effects of MTX on normal cells is reduced by The toxic effects of MTX on normal cells is reduced by
administering folinic acid (leucovorin)administering folinic acid (leucovorin) This is called leucovorin rescue **** This is called leucovorin rescue **** Higher the dose of MTX more the leucovorin you give**Higher the dose of MTX more the leucovorin you give**
2121
Leucovorin RescueLeucovorin Rescue
Mechanism of action of methotrexate Mechanism of action of methotrexate and the effect of administration of and the effect of administration of leucovorin.leucovorin.
FH2 = dihydrofolateFH2 = dihydrofolate FH4 = tetrahydrofolateFH4 = tetrahydrofolate dTMP = deoxythymidine dTMP = deoxythymidine
monophosphatemonophosphate dUMP = deoxyuridine mono dUMP = deoxyuridine mono
phosphate. phosphate.
2222
6-Mercaptopurine (6-MP) & Thioguanine6-Mercaptopurine (6-MP) & Thioguanine
Both 6-MP and Thioguanine are Both 6-MP and Thioguanine are activated by HGPRT to toxic activated by HGPRT to toxic nucleotides that inhibit several nucleotides that inhibit several enzymes involved in purine enzymes involved in purine metabolismmetabolism
***Resistance is due to cancer cells ***Resistance is due to cancer cells having having d activity of HGPRTd activity of HGPRT
Cancer cells also Cancer cells also es alkaline es alkaline phosphatase that inactivate toxic phosphatase that inactivate toxic nucleotidesnucleotides
2323
6-MP & Allopurinol6-MP & Allopurinol 6-MP is metabolized in the liver by xanthine oxidase and 6-MP is metabolized in the liver by xanthine oxidase and
the inactive metabolites are excreted in the urinethe inactive metabolites are excreted in the urine Allopurinol is used frequently to treat/prevent Allopurinol is used frequently to treat/prevent
hyperuricemia caused by many anticancer drugs.hyperuricemia caused by many anticancer drugs. If Allopurinol is used with 6-MP then the dose of 6-MP is If Allopurinol is used with 6-MP then the dose of 6-MP is
reduced by more than 75%reduced by more than 75%
2424
Cytarabine (Ara-C)Cytarabine (Ara-C) Cytarabine arabinoside is a pyrimidine antimetabolite Cytarabine arabinoside is a pyrimidine antimetabolite
The drug is activated by kinases to AraCTPThe drug is activated by kinases to AraCTP This acts as an inhibitor of DNA polymeraseThis acts as an inhibitor of DNA polymerase
Of all antimetabolites, this is the most specific for S phase of Of all antimetabolites, this is the most specific for S phase of tumor cell cycletumor cell cycle
It is an important component in acute lukemia regimensIt is an important component in acute lukemia regimens
ADR: ADR: High doses cause neurotoxicity (cerebellar dysfunction and High doses cause neurotoxicity (cerebellar dysfunction and
peripheral neuritis)peripheral neuritis) Hand-foot syndromeHand-foot syndrome
2525
5-FU5-FUMechanism of the cytotoxic action of 5-FUMechanism of the cytotoxic action of 5-FU
5-FU is converted to 5-FdUMP, 5-FU is converted to 5-FdUMP, which competes with deoxyuridine which competes with deoxyuridine monophosphate (dUMP) for the monophosphate (dUMP) for the enzyme thymidylate synthetase.enzyme thymidylate synthetase.
5-FU = 5-fluorouracil5-FU = 5-fluorouracil 5-FUR = 5-fluorouridine5-FUR = 5-fluorouridine 5-FUMP = 5-fluorouridine monophosphate5-FUMP = 5-fluorouridine monophosphate 5-FUDP = 5-fluorouridine diphosphate5-FUDP = 5-fluorouridine diphosphate 5-FUTP = 5-fluorouridine triphosphate5-FUTP = 5-fluorouridine triphosphate dUMP = deoxyuridine monophosphatedUMP = deoxyuridine monophosphate dTMP = deoxythymidine monophosphatedTMP = deoxythymidine monophosphate 5-FdUMP = 5-fluorodeoxyuridine 5-FdUMP = 5-fluorodeoxyuridine
monophosphate. monophosphate.
2626
5-FU causes, “thymidineless death” of cells5-FU causes, “thymidineless death” of cells
Resistance is due to Resistance is due to d activation of 5-FU and increased thymidylate d activation of 5-FU and increased thymidylate synthase activitysynthase activity
Uses Uses Metastatic carcinomas of the Metastatic carcinomas of the breast and the GI tract, hepatomabreast and the GI tract, hepatoma
Carcinomas of the Carcinomas of the ovary, cervix, urinary bladder, prostate, pancreas, ovary, cervix, urinary bladder, prostate, pancreas, and and oropharyngeal areasoropharyngeal areas
Combined with levamisole for Rx of Combined with levamisole for Rx of colon cancercolon cancer
ADR:ADR: nausea, mucositis, diarrhea, nausea, mucositis, diarrhea, hand and foot syndromehand and foot syndrome, Alopecia, , Alopecia,
hyperpigmentation, neurologic deficits, bone marrow depressionhyperpigmentation, neurologic deficits, bone marrow depression
2727
THANK YOUTHANK YOU